HSCT Vs Stem Cells (Vs Revimmune?)

Discuss stem cells, adult and embryonic, and their therapeutic potential for MS here.

HSCT Vs Stem Cells (Vs Revimmune?)

Postby Looking88 » Tue May 03, 2011 5:28 pm

Is it time to give Campauth a second look? If you were just wanting to stop progression? How does 65% compare to HSCT?

Results of the five-year review showed:

an estimated 65 percent of alemtuzumab-treated patients were free of clinically-active disease, compared to 27 percent of patients taking Rebif (p<0.0001). To be free of clinically-active disease, MS patients in the trial were both relapse-free and without a sustained increase in disability as measured by the Expanded Disability Status Scale (EDSS) through five years;

an estimated 72 percent of alemtuzumab-treated patients were relapse-free compared to 41 percent of patients taking Rebif; and

an estimated 87 percent of alemtuzumab-treated patients were free of sustained accumulation of disability compared to 62 percent of patients taking Rebif (previously reported).
User avatar
Looking88
Family Member
 
Posts: 44
Joined: Fri Dec 24, 2010 4:00 pm

Advertisement

Re: HSCT Vs Stem Cells (Vs Revimmune?)

Postby georgegoss » Wed May 04, 2011 3:16 pm

Looking88 wrote:Is it time to give Campauth a second look? If you were just wanting to stop progression? How does 65% compare to HSCT?

Results of the five-year review showed:

an estimated 65 percent of alemtuzumab-treated patients were free of clinically-active disease, compared to 27 percent of patients taking Rebif (p<0.0001). To be free of clinically-active disease, MS patients in the trial were both relapse-free and without a sustained increase in disability as measured by the Expanded Disability Status Scale (EDSS) through five years;

an estimated 72 percent of alemtuzumab-treated patients were relapse-free compared to 41 percent of patients taking Rebif; and

an estimated 87 percent of alemtuzumab-treated patients were free of sustained accumulation of disability compared to 62 percent of patients taking Rebif (previously reported).


Hi Looking 88,

No doubt Campath is a good drug. Much better than the CRAB agents. I wish it had been available when I was diagnosed in 1996.

If one just wants to "stop" the underlying MS disease activity & progression, here's how HSCT performs (based on the clinical trials completed to date) based on disease status at time of treatment (number shown here is based upon the number of people from the total MS population, not the percentage of measured improvement in any given individual which is all over the map):

Early RRMS = 100% stopping of disease activity
Advanced SPMS = 79% stopping of disease activity
Advanced PPMS = 66% stopping of disease activity

I graphed it out on a single page here. . . .

<shortened url>

And then comparing Campath with HSCT curative efficacy, here's what Dr. Richard Burt had to say relative this subject. . . .

http://www.youtube.com/watch?v=msYTOSo4 ... re=channel
.
User avatar
georgegoss
Family Elder
 
Posts: 283
Joined: Sat Oct 30, 2010 3:00 pm
Location: California


Return to Stem Cells

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service